Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective

Despite the fact that astrocytes are the most abundant glial cells, critical for brain function, few studies have dealt with their possible role in neurodegenerative diseases like Parkinson’s disease (PD). This article explores relevant evidence on the involvement of astrocytes in experimental PD ne...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucas Udovin, Cecilia Quarracino, María I. Herrera, Francisco Capani, Matilde Otero-Losada, Santiago Perez-Lloret
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2020/1859431
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554976371539968
author Lucas Udovin
Cecilia Quarracino
María I. Herrera
Francisco Capani
Matilde Otero-Losada
Santiago Perez-Lloret
author_facet Lucas Udovin
Cecilia Quarracino
María I. Herrera
Francisco Capani
Matilde Otero-Losada
Santiago Perez-Lloret
author_sort Lucas Udovin
collection DOAJ
description Despite the fact that astrocytes are the most abundant glial cells, critical for brain function, few studies have dealt with their possible role in neurodegenerative diseases like Parkinson’s disease (PD). This article explores relevant evidence on the involvement of astrocytes in experimental PD neurodegeneration from a molecular signaling perspective. For a long time, astrocytic proliferation was merely considered a byproduct of neuroinflammation, but by the time being, it is clear that astrocytic dysfunction plays a far more important role in PD pathophysiology. Indeed, ongoing experimental evidence suggests the importance of astrocytes and dopaminergic neurons’ cross-linking signaling pathways. The Wnt-1 (wingless-type MMTV integration site family, member 1) pathway regulates several processes including neuron survival, synapse plasticity, and neurogenesis. In PD animal models, Frizzled (Fzd) neuronal receptors’ activation by the Wnt-1 normally released by astrocytes following injuries leads to β-catenin-dependent gene expression, favoring neuron survival and viability. The transient receptor potential vanilloid 1 (TRPV1) capsaicin receptor also participates in experimental PD genesis. Activation of astrocyte TRPV1 receptors by noxious stimuli results in reduced inflammatory response and increased ciliary neurotrophic factor (CNTF) synthesis, which enhances neuronal survival and differentiation. Another major pathway involves IκB kinase (IKK) downregulation by ARL6ip5 (ADP-ribosylation-like factor 6 interacting protein 5, encoded by the cell differentiation-associated, JWA, gene). Typically, IKK releases the proinflammatory NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) molecule from its inhibitor. Therefore, by downregulating NF-κB inhibitor, ARL6ip5 promotes an anti-inflammatory response. The evidence provided by neurotoxin-induced PD animal models guarantees further research on the neuroprotective potential of normalizing astrocyte function in PD.
format Article
id doaj-art-d372a0f3d28a4d9f86cf33fda100b4cc
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-d372a0f3d28a4d9f86cf33fda100b4cc2025-02-03T05:49:55ZengWileyNeural Plasticity2090-59041687-54432020-01-01202010.1155/2020/18594311859431Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling PerspectiveLucas Udovin0Cecilia Quarracino1María I. Herrera2Francisco Capani3Matilde Otero-Losada4Santiago Perez-Lloret5Institute of Cardiological Research, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Marcelo T. de Alvear 2270, C1122 Buenos Aires, ArgentinaInstitute of Cardiological Research, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Marcelo T. de Alvear 2270, C1122 Buenos Aires, ArgentinaInstitute of Cardiological Research, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Marcelo T. de Alvear 2270, C1122 Buenos Aires, ArgentinaPontifical Catholic University of Argentina, Buenos Aires, ArgentinaInstitute of Cardiological Research, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Marcelo T. de Alvear 2270, C1122 Buenos Aires, ArgentinaInstitute of Cardiological Research, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Marcelo T. de Alvear 2270, C1122 Buenos Aires, ArgentinaDespite the fact that astrocytes are the most abundant glial cells, critical for brain function, few studies have dealt with their possible role in neurodegenerative diseases like Parkinson’s disease (PD). This article explores relevant evidence on the involvement of astrocytes in experimental PD neurodegeneration from a molecular signaling perspective. For a long time, astrocytic proliferation was merely considered a byproduct of neuroinflammation, but by the time being, it is clear that astrocytic dysfunction plays a far more important role in PD pathophysiology. Indeed, ongoing experimental evidence suggests the importance of astrocytes and dopaminergic neurons’ cross-linking signaling pathways. The Wnt-1 (wingless-type MMTV integration site family, member 1) pathway regulates several processes including neuron survival, synapse plasticity, and neurogenesis. In PD animal models, Frizzled (Fzd) neuronal receptors’ activation by the Wnt-1 normally released by astrocytes following injuries leads to β-catenin-dependent gene expression, favoring neuron survival and viability. The transient receptor potential vanilloid 1 (TRPV1) capsaicin receptor also participates in experimental PD genesis. Activation of astrocyte TRPV1 receptors by noxious stimuli results in reduced inflammatory response and increased ciliary neurotrophic factor (CNTF) synthesis, which enhances neuronal survival and differentiation. Another major pathway involves IκB kinase (IKK) downregulation by ARL6ip5 (ADP-ribosylation-like factor 6 interacting protein 5, encoded by the cell differentiation-associated, JWA, gene). Typically, IKK releases the proinflammatory NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) molecule from its inhibitor. Therefore, by downregulating NF-κB inhibitor, ARL6ip5 promotes an anti-inflammatory response. The evidence provided by neurotoxin-induced PD animal models guarantees further research on the neuroprotective potential of normalizing astrocyte function in PD.http://dx.doi.org/10.1155/2020/1859431
spellingShingle Lucas Udovin
Cecilia Quarracino
María I. Herrera
Francisco Capani
Matilde Otero-Losada
Santiago Perez-Lloret
Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective
Neural Plasticity
title Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective
title_full Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective
title_fullStr Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective
title_full_unstemmed Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective
title_short Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson’s Disease Animal Models from a Molecular Signaling Perspective
title_sort role of astrocytic dysfunction in the pathogenesis of parkinson s disease animal models from a molecular signaling perspective
url http://dx.doi.org/10.1155/2020/1859431
work_keys_str_mv AT lucasudovin roleofastrocyticdysfunctioninthepathogenesisofparkinsonsdiseaseanimalmodelsfromamolecularsignalingperspective
AT ceciliaquarracino roleofastrocyticdysfunctioninthepathogenesisofparkinsonsdiseaseanimalmodelsfromamolecularsignalingperspective
AT mariaiherrera roleofastrocyticdysfunctioninthepathogenesisofparkinsonsdiseaseanimalmodelsfromamolecularsignalingperspective
AT franciscocapani roleofastrocyticdysfunctioninthepathogenesisofparkinsonsdiseaseanimalmodelsfromamolecularsignalingperspective
AT matildeoterolosada roleofastrocyticdysfunctioninthepathogenesisofparkinsonsdiseaseanimalmodelsfromamolecularsignalingperspective
AT santiagoperezlloret roleofastrocyticdysfunctioninthepathogenesisofparkinsonsdiseaseanimalmodelsfromamolecularsignalingperspective